| Current Price | $55.81 | Mkt Cap | $135.43B |
|---|---|---|---|
| Open | $55.72 | P/E Ratio | 13.60 |
| Prev. Close | $56.35 | Div. (Yield) | 2.09 (2.70%) |
| Daily Range | $55.66 - $55.96 | Volume | 919,053 |
| 52-Wk Range | $51.60 - $64.82 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Seattle Genetics' Adcetris Launch: Second Survey Reveals Additional Insights 2/10/2012 10:18:50 AM -
- University Teams Tap Mobile Phones and Social Networks to Fight Non-communicable Diseases 2/9/2012 4:30:00 PM -
- 5 Income Generating Stocks With Strong Future Growth Prospects 2/9/2012 1:19:14 PM -
- FDA Sets Shortcut Path for Biosimilar Drugs 2/9/2012 12:33:00 PM -
- Generic Challenge for UTHR's Remodulin - Analyst Blog 2/8/2012 3:36:01 PM
- US Judge Rules For FDA In Generic Lovenox Case 2/7/2012 10:50:59 AM
- Risk-Reward Balances for Endo Pharma - Analyst Blog 2/1/2012 12:20:01 PM
- Risk-Reward Balances for Endo Pharma - Analyst Blog 2/1/2012 12:20:01 PM
| Subject | Recs | Author | Date |
|---|



